Alimera Sciences Initiates Landmark NEW DAY Clinical Trial to Evaluate ILUVIEN® as Baseline Therapy for Diabetic Macular Edema

Ads

You May Also Like

AIT Therapeutics Reports Year End 2017 Financial Results

Expects first regulatory filing for the NO Generator and Delivery System in persistent pulmonary ...

Epistem management buy-out

MANCHESTER, United Kingdom, June 12, 2018 (GLOBE NEWSWIRE) -- Epistem, the Manchester UK-based Contract ...

Aduro Biotech to Present at Two Upcoming Investor Conferences

BERKELEY, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced ...